Efficacy of Electrical Spinal Cord Stimulation with Neuromodulating Medications: A Systematic Review.

Q3 Medicine Psychopharmacology bulletin Pub Date : 2020-10-15
Weston Case Nadherny, Kenneth Fiala, Ivan Urits, Omar Viswanath, Alaa Abd-Elsayed
{"title":"Efficacy of Electrical Spinal Cord Stimulation with Neuromodulating Medications: A Systematic Review.","authors":"Weston Case Nadherny,&nbsp;Kenneth Fiala,&nbsp;Ivan Urits,&nbsp;Omar Viswanath,&nbsp;Alaa Abd-Elsayed","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Chronic pain is a prevalent and debilitating problem for millions of people and spinal cord stimulation (SCS) is one option for treatment. It has been shown to have membrane stabilizing properties and is often used in conjunction with medications that are also believed to offer pain control through membrane stabilization.</p><p><strong>Objective: </strong>The goal of this review is to analyze the effects of SCS combined with medications to evaluate for augmentative therapeutic effect.</p><p><strong>Setting: </strong>Systematic review.</p><p><strong>Methods: </strong>A systematic computerized search of the literature was conducted using PubMed, the Cochrane Library, and EMBASE for articles published in English.</p><p><strong>Results: </strong>We report three articles that discuss the potential for augmentative effects of medication in combination with SCS. Located articles related primarily to SCS combined with Gabapentin, TCA, or SNRI.</p><p><strong>Limitations: </strong>The limited number of articles reflects a need for more investigation in this area.</p><p><strong>Conclusion: </strong>Based on the suspected mechanisms for SCS and neuromodulating medications, there is reason to believe adding these medical therapies may enhance the effects of SCS.</p>","PeriodicalId":21069,"journal":{"name":"Psychopharmacology bulletin","volume":"50 4 Suppl 1","pages":"67-73"},"PeriodicalIF":0.0000,"publicationDate":"2020-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7901128/pdf/PB-50-4S1-67.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Psychopharmacology bulletin","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Chronic pain is a prevalent and debilitating problem for millions of people and spinal cord stimulation (SCS) is one option for treatment. It has been shown to have membrane stabilizing properties and is often used in conjunction with medications that are also believed to offer pain control through membrane stabilization.

Objective: The goal of this review is to analyze the effects of SCS combined with medications to evaluate for augmentative therapeutic effect.

Setting: Systematic review.

Methods: A systematic computerized search of the literature was conducted using PubMed, the Cochrane Library, and EMBASE for articles published in English.

Results: We report three articles that discuss the potential for augmentative effects of medication in combination with SCS. Located articles related primarily to SCS combined with Gabapentin, TCA, or SNRI.

Limitations: The limited number of articles reflects a need for more investigation in this area.

Conclusion: Based on the suspected mechanisms for SCS and neuromodulating medications, there is reason to believe adding these medical therapies may enhance the effects of SCS.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
神经调节药物对脊髓电刺激的疗效:一项系统综述。
背景:慢性疼痛是数百万人普遍存在的问题,脊髓刺激(SCS)是治疗的一种选择。它已被证明具有膜稳定特性,并且经常与药物一起使用,这些药物也被认为可以通过膜稳定来控制疼痛。目的:本综述的目的是分析SCS联合药物治疗的效果,以评价其增强治疗效果。设置:系统评价。方法:使用PubMed、Cochrane图书馆和EMBASE对已发表的英文文章进行系统的计算机检索。结果:我们报告了三篇文章,讨论了药物联合SCS的潜在增强作用。定位主要与SCS联合加巴喷丁、TCA或SNRI相关的文章。局限性:有限的文章数量反映了在这个领域需要更多的调查。结论:基于对SCS和神经调节药物作用机制的推测,我们有理由相信加入这些药物治疗可以增强SCS的作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Psychopharmacology bulletin
Psychopharmacology bulletin PHARMACOLOGY & PHARMACY-PSYCHIATRY
CiteScore
2.70
自引率
0.00%
发文量
32
期刊介绍: Information not localized
期刊最新文献
Takotsubo Cardiomyopathy Related to Duloxetine-Atomoxetine Combination in an Adolescent with ADHD and Comorbid GAD. On the Origins of MAOI Misconceptions: Reaffirming their Role in Melancholic Depression. Alzheimer's and Dementia Guidelines and Tables. Captagone & Morbid Jealousy. Are Standardized Tests Sensitive to Early Cognitive Change in Parkinson's Disease?
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1